Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities

被引：15
|
作者：
De, D. [1 ]
Kaushik, A. [1 ]
Handa, S. [1 ]
Mahajan, R. [1 ]
Schmidt, E. [2 ,3 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Dermatol Venereol & Leprol, Chandigarh, India
[2] Univ Lubeck, Dept Dermatol, Lubeck, Germany
[3] Univ Lubeck, Lubeck Inst Expt Dermatol LIED, Lubeck, Germany
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 35卷 / 07期
关键词：
IGE;
D O I：
10.1111/jdv.17229
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E469 / E472
页数：4
相关论文
共 50 条
  • [41] Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid
    Kwon, Il Joo
    Kim, Taehee
    Yoo, Dae San
    Min, Seoyeon
    Kim, Soo-Chan
    Kim, Jong Hoon
    JOURNAL OF DERMATOLOGY, 2023, 50 (05): : 705 - 709
  • [42] Prevalence and Impact of Co-morbidities on Treatment of Breast Cancer
    Tao, M.
    Khalid, N.
    White, J. R.
    Owen, J. B.
    Pierce, L. J.
    Wilson, J. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S557 - S557
  • [43] IMPACT OF CO-MORBIDITIES ON DISEASE SEVERITY AND TREATMENT STRATEGY IN PATIENTS WITH INFLAMMATORY ARTHRITIS
    Symmons, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 47 - 48
  • [44] Methylphenidate Treatment in Germany - Are Co-Morbidities Taken into Account?
    Lindemann, Christina
    Angela, Kraut
    Ingo, Langner
    Rafael, Mikolajczyk
    Edeltraut, Garbe
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S226 - S226
  • [45] The treatment of long-term co-morbidities in older patients with metastatic cancer
    Cashman, J.
    Wright, J.
    Ring, A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S49 - S49
  • [46] Does successful treatment of overactive bladder improve co-morbidities in patients with nocturia?
    Chin, Kai Sin
    Rose, Georgie E.
    Ervin, Claire F.
    Ong, Tee Juan
    Whishaw, David M.
    Bower, Wendy F.
    AUSTRALASIAN JOURNAL ON AGEING, 2019, 38 (04) : 242 - 248
  • [47] Interstitial cystitisCost, treatment and co-morbidities in an employed population
    Eric Q. Wu
    Howard Birnbaum
    Milena Mareva
    Andrew Parece
    Zihong Huang
    David Mallett
    Haya Taitel
    PharmacoEconomics, 2006, 24 (1) : 55 - 65
  • [48] The Effect Of Co-Morbidities On Productivity Loss In Patients With Asthma
    Ehteshami-Afshar, S.
    FitzGerald, J. M.
    Carlsten, C.
    Rousseau, R.
    Tan, W. C.
    Rolf, J.
    Sadatsafavi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [49] COSTS OF CO-MORBIDITIES IN PSORIASIS PATIENTS IN THE UNITED STATES
    Tian, H.
    Mallya, U.
    Shu, M.
    VALUE IN HEALTH, 2014, 17 (03) : A285 - A285
  • [50] Psychotherapeutic Groups for Elderly Patients with Multiple Co-Morbidities
    Schwartz, K.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2016, 85 : 80 - 80
12345